Safety and Pharmacokinetics of SAD/MAD Oral Doses of SRP-3D (DA)
Clinical trial NCT05484414 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05484414
- Sponsor
- South Rampart Pharma, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-16
- Primary completion
- 2025-12-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.